M&A Deal Summary

Apotex Acquires Searchlight Pharma

On April 2, 2024, Apotex acquired life science company Searchlight Pharma

Acquisition Highlights
  • This is Apotex’s 4th transaction in the Life Science sector.
  • This is Apotex’s 1st transaction in Canada.
  • This is Apotex’s 1st transaction in Quebec.

M&A Deal Summary

Date 2024-04-02
Target Searchlight Pharma
Sector Life Science
Buyer(s) Apotex
Deal Type Add-on Acquisition
Advisor(s) Bloom Burton & Co. (Financial)
Davies Ward Phillips & Vineberg (Legal)

Target

Searchlight Pharma

Montreal, Quebec, Canada
Searchlight Pharma is a specialty healthcare company that offers acquisition, commercialization, and focused development of innovative and unique specialty healthcare products. Searchlight Pharma was founded in 2015 and is based in Montreal, Quebec.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Apotex

Toronto, Ontario, Canada

Category Company
Founded 1974
Sector Life Science
DESCRIPTION

Apotex is an independent pharmaceutical company committed to R&D, manufacturing, and distributing a broad range of high-quality, affordable medicines to patients, healthcare providers, payers, and governments worldwide. Apotex was founded in 1974 and is based in Toronto, Ontario.


DEAL STATS #
Overall 4 of 4
Sector: Life Science M&A 4 of 4
Type: Add-on Acquisition M&A Deals 1 of 1
State: Quebec M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-04-24 Aveva

Miramar, Florida, United States

AVEVA is a transdermal drug delivery provider. The company provides pharmaceutical partners with fully integrated, controlled-release transdermal products that fulfill unmet market needs or supply high-quality, affordable brand equivalents. Aveva was founded in 1991 and is based in Miramar, Florida.

Sell -